Fig. 5

Effect on Saos-2 subcutaneous xenograft tumor in nude mouse model following bi-weekly IV injection for 30 days of doxorubicin-conjugated BP NPs (1 µg doxorubicin per injection), free doxorubicin (1 µg per injection) and non-conjugated BP NPs (0.2 mg per injection). *T test p < 0.05 and error bars represent standard deviation